BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Campagno KE, Mitchell CH. The P2X7 Receptor in Microglial Cells Modulates the Endolysosomal Axis, Autophagy, and Phagocytosis. Front Cell Neurosci 2021;15:645244. [PMID: 33790743 DOI: 10.3389/fncel.2021.645244] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 19.0] [Reference Citation Analysis]
Number Citing Articles
1 Xiao Q, Sun X, Cui Z, Hu X, Yang T, Guan J, Gu Y, Li H, Zhang H. TMEM16F may be a new therapeutic target for Alzheimer’s disease. Neural Regen Res 2023;18:643. [DOI: 10.4103/1673-5374.350211] [Reference Citation Analysis]
2 Zhao L, Hou C, Yan N. Neuroinflammation in retinitis pigmentosa: Therapies targeting the innate immune system. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1059947] [Reference Citation Analysis]
3 Yuan J, Zhu Q, Zhang X, Wen Z, Zhang G, Li N, Pei Y, Wang Y, Pei S, Xu J, Jia P, Peng C, Lu W, Qin J, Cao Q, Xiao Y. Ezh2 competes with p53 to license lncRNA Neat1 transcription for inflammasome activation. Cell Death Differ 2022;29:2009-2023. [DOI: 10.1038/s41418-022-00992-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Yang C, Li X, Feng X, Chen Y, Feng J, Jia J, Wei J, Zhou J, Rios F. Activation of LRP1 Ameliorates Cerebral Ischemia/Reperfusion Injury and Cognitive Decline by Suppressing Neuroinflammation and Oxidative Stress through TXNIP/NLRP3 Signaling Pathway in Mice. Oxidative Medicine and Cellular Longevity 2022;2022:1-23. [DOI: 10.1155/2022/8729398] [Reference Citation Analysis]
5 Fehér J, Élő Á, István L, Nagy ZZ, Radák Z, Scuderi G, Artico M, Kovács I. Microbiota mitochondria disorders as hubs for early age-related macular degeneration. Geroscience 2022. [PMID: 35978068 DOI: 10.1007/s11357-022-00620-5] [Reference Citation Analysis]
6 Liu Q, Huang Y, Duan M, Yang Q, Ren B, Tang F. Microglia as Therapeutic Target for Radiation-Induced Brain Injury. IJMS 2022;23:8286. [DOI: 10.3390/ijms23158286] [Reference Citation Analysis]
7 Mckenzie ADJ, Garrett TR, Werry EL, Kassiou M. Purinergic P2X7 Receptor: A Therapeutic Target in Amyotrophic Lateral Sclerosis. ACS Chem Neurosci 2022;13:1479-90. [PMID: 35512313 DOI: 10.1021/acschemneuro.2c00133] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Nobili P, Shen W, Milicevic K, Bogdanovic Pristov J, Audinat E, Nikolic L. Therapeutic Potential of Astrocyte Purinergic Signalling in Epilepsy and Multiple Sclerosis. Front Pharmacol 2022;13:900337. [DOI: 10.3389/fphar.2022.900337] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
9 Santos SACS, Persechini PM, Henriques-Santos BM, Bello-Santos VG, Castro NG, Costa de Sousa J, Genta FA, Santiago MF, Coutinho-Silva R, Savio LEB, Kurtenbach E. P2X7 Receptor Triggers Lysosomal Leakage Through Calcium Mobilization in a Mechanism Dependent on Pannexin-1 Hemichannels. Front Immunol 2022;13:752105. [PMID: 35222364 DOI: 10.3389/fimmu.2022.752105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Jaganjac M, Milkovic L, Zarkovic N, Zarkovic K. Oxidative stress and regeneration. Free Radic Biol Med 2022;181:154-65. [PMID: 35149216 DOI: 10.1016/j.freeradbiomed.2022.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
11 Bianca Maria Platania C, Drago F, Bucolo C. The P2X7 receptor as a new pharmacological target for retinal diseases. Biochemical Pharmacology 2022. [DOI: 10.1016/j.bcp.2022.114942] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Udayar V, Chen Y, Sidransky E, Jagasia R. Lysosomal dysfunction in neurodegeneration: emerging concepts and methods. Trends Neurosci 2022:S0166-2236(21)00252-6. [PMID: 35034773 DOI: 10.1016/j.tins.2021.12.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
13 Francistiová L, Vörös K, Lovász Z, Dinnyés A, Kobolák J. Detection and Functional Evaluation of the P2X7 Receptor in hiPSC Derived Neurons and Microglia-Like Cells. Front Mol Neurosci 2022;14:793769. [DOI: 10.3389/fnmol.2021.793769] [Reference Citation Analysis]
14 Ravichandran KA, Heneka MT. Inflammasome activation in neurodegenerative diseases. Essays Biochem 2021;65:885-904. [PMID: 34846519 DOI: 10.1042/EBC20210021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
15 Pišlar A, Bolčina L, Kos J. New Insights into the Role of Cysteine Cathepsins in Neuroinflammation. Biomolecules 2021;11:1796. [PMID: 34944440 DOI: 10.3390/biom11121796] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Dragić M, Mitrović N, Adžić M, Nedeljković N, Grković I. Microglial- and Astrocyte-Specific Expression of Purinergic Signaling Components and Inflammatory Mediators in the Rat Hippocampus During Trimethyltin-Induced Neurodegeneration. ASN Neuro 2021;13:17590914211044882. [PMID: 34569324 DOI: 10.1177/17590914211044882] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
17 Campagno KE, Lu W, Jassim AH, Albalawi F, Cenaj A, Tso HY, Clark SP, Sripinun P, Gómez NM, Mitchell CH. Rapid morphologic changes to microglial cells and upregulation of mixed microglial activation state markers induced by P2X7 receptor stimulation and increased intraocular pressure. J Neuroinflammation 2021;18:217. [PMID: 34544431 DOI: 10.1186/s12974-021-02251-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
18 Elmazoglu Z, Kayhan H, Santamaría A, Rangel-López E, Uğur PK, Ceylan A, Aschner M, Karasu Ç. Platinum nanoparticles Protect Against Lipopolysaccharide-Induced Inflammation in Microglial BV-2 Cells via Decreased Oxidative Damage and Increased Phagocytosis. Neurochem Res 2021;46:3325-41. [PMID: 34432181 DOI: 10.1007/s11064-021-03434-7] [Reference Citation Analysis]
19 Jassim AH, Inman DM, Mitchell CH. Crosstalk Between Dysfunctional Mitochondria and Inflammation in Glaucomatous Neurodegeneration. Front Pharmacol 2021;12:699623. [PMID: 34366851 DOI: 10.3389/fphar.2021.699623] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 19.0] [Reference Citation Analysis]
20 Sepehrinezhad A, Gorji A, Sahab Negah S. SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism. Inflammopharmacology 2021;29:1049-59. [PMID: 34241783 DOI: 10.1007/s10787-021-00845-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]